Piper Sandler lowered the firm’s price target on Zoetis (ZTS) to $200 from $210 and keeps an Overweight rating on the shares. The firm cites the divestiture of Zoetis’ MFA assets, as well as to incorporate anticipated Fx headwinds, and unfavorable interest income due to lower interest rates.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZTS:
- Buy Recommendation for Zoetis: Strong Growth Prospects Amid Competitive Challenges
- Zoetis Announces Q2 2025 Dividend Payment
- Positive Outlook for Zoetis Boosted by Librela Label Update and Market Potential
- Librela U.S. label update ‘better than feared’ for Zoetis, says Morgan Stanley
- Updated Zoetis label for Librela ‘a relief,’ says Piper Sandler